GATC Trademark

Trademark Overview

On Friday, April 15, 2022, a trademark application was filed for GATC with the United States Patent and Trademark Office. The USPTO has given the GATC trademark a serial number of 97365586. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by GATC Health Corp. The GATC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery services; Pharmaceutical drug development services
gatc

General Information

Serial Number97365586
Word MarkGATC
Filing DateFriday, April 15, 2022
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7503132
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 7, 2023

Trademark Statements

Goods and ServicesDrug discovery services; Pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 20, 2022
Primary Code042
First Use Anywhere DateWednesday, April 7, 2021
First Use In Commerce DateWednesday, April 20, 2022

Trademark Owner History

Party NameGATC Health Corp
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614
Party NameGATC Health Corp
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614
Party NameGATC Health Corp
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92614

Trademark Events

Event DateEvent Description
Tuesday, April 19, 2022NEW APPLICATION ENTERED
Wednesday, April 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 28, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023ASSIGNED TO EXAMINER
Thursday, February 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 7, 2023PUBLISHED FOR OPPOSITION
Monday, April 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023USE AMENDMENT FILED
Tuesday, May 2, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 2, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, November 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 9, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 9, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 11, 2024ASSIGNED TO LIE
Wednesday, August 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, July 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

gatc drug services development pharmaceutical discovery